Navigation Links
VerifyNow Aspirin Assay

ProductsVerifyNow Aspirin Assay
Company Accumetrics
Item VerifyNow Aspirin Assay
Features Each single-use disposable assay device, such as the VerifyNow IIb/IIIa or VerifyNow Aspirin Assay, contains all needed reagents to provide analytical results for a specific assay. Assay devices are individually pouched and may be used until the expiration date printed on each kit box and foil pouch.

The assay device consists of the following components:

  • Finger Grip: Each assay device has a handle with which the user can insert or remove the assay device from the assay device port.
  • Staging Well: The blood sample is held in this area for temperature stabilization prior to analysis.
  • Assay Device Spot Code: Each assay device is labeled with a unique spot code. Upon insertion of the assay device into the assay device port, the instrument automatically scans the spot code and determines which assay is being performed, records the lot number, and verifies that the assay device has not expired.
  • Sample Well: The sample well is the area of the assay device where the blood collection tube is inserted. The well contains a Blood Collection Tube Spike for sampling directly from a closed blood collection tube. A protective sheath is removed from the assay device spike before use.
  • Humidity Indicator: Each assay device has a humidity sensor to determine whether the assay device has been exposed to excess humidity.
  • Mixing Chamber/Detection Wells: The wells contain all necessary reagents for the specific assays.
Description Aspirin is the medication most commonly prescribed for the prevention of life threatening vascular events such as heart attacks and strokes. However, a number of studies have shown that as many as 30% of people taking daily aspirin therapy to prevent a recurrent vascular event may not be receiving aspirin's full benefits. These people are at greater risk for a heart attack or stroke.

The VerifyNow Aspirin Assay is a qualitative test to aid in the detection of platelet dysfunction due to aspirin (ASA) ingestion in citrated whole blood for the point of care or laboratory setting.

The VerifyNow System is a turbidimetric based optical detection system which measures platelet induced aggregation as an increase in light transmittance. The system consists of an instrument, a disposable assay device and controls. The assay device contains reagents based on microbead agglutination technology. The assay device contains a lyophilized preparation of human fibrinogen-coated beads, platelet agonist, preservative and buffer. The patient sample is 3.2% citrated whole blood, which is automatically dispensed from the blood collection tube into the assay device by the instrument, with no blood handling required by the user.

Info Accumetrics
Customer Service: (800) 643-1640
Web site: http://www.accumetrics.com

Related medicine products :

1. VerifyNow System
2. VerifyNow IIb/IIIa Assay
3. VerifyNow Clopidogrel Assay
4. VerifyNow (Ultegra) System
5. Uric Acid Enzymatic Assay
6. Lithium Enzymatic Assay Kit
7. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
8. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
9. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
10. Procleix HIV-1/HCV Assay
11. VERSANT HIV RNA 3.0 Assay (bDNA)
... 10% Ash: 1.6% Gel ... Gel pH (1.5%): 5.0 7.0 Gel Point (1.5%): ... A (430 nm, 1.5%): 0.150 Resistance ... 25,000 Ohms EEO (-m r ): ...
... easy and economical generation of a hypoxic ... Chamber utilizes a surface-type seal where all ... by a stainless steel ring clamp for ... and semi-spherical top and bottom provide minimum ...
... of miniTHERM incubators is available, ensuring the ... for their specific requirements. miniTHERM incubators have ... and extremely space saving. Their size corresponds ... is possible to stack up to three ...
In microbiological laboratories and for in vitro fertilization, as well as in cancer research or tissue engineering, the Heraeus CO2 incubator BBD 6220 provides the best contamination protection and ...
Medicine Products:
(Date:4/18/2014)... 2014) Benaroya Research Institute at Virginia Mason (BRI) ... particular molecule in metastatic breast cancer reduces both the ... metastases. BRI scientists have found in models of the ... 60 - 80 percent and can keep the tumor ... million five-year grant comes from the National Cancer Institute ...
(Date:4/17/2014)... The presence of chronic inflammation in benign prostate ... cancer, and this association was found even in ... to a study published in Cancer Epidemiology, ... American Association for Cancer Research. , An analysis ... of the placebo arm of the Prostate Cancer ...
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... (April 16, 2014) The cause of neuronal death ... study proposes that neurons may be mistaken for foreign ... similar to the way autoimmune diseases like type I ... cells. The study was published April 16, 2014, in ... and likely controversial, idea in Parkinson,s disease; but if ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2
... Serves Up Insider Tips and Recipes to Enhance Any Dining ... of Acid Wear on Teeth, PITTSBURGH, Oct. 17 Those ... about the toll their diets can sometimes take,on tooth enamel as ... are consuming healthier fare such as fruits, vegetables, diet,sodas and sports ...
... aims to develop pharmaceutical therapeutics for blinding eye diseases, ... ... Retinopathy, OKLAHOMA CITY, Oct. 17 Charlesson, LLC ... Research (SBIR) awards from the National Institutes of Health,(NIH), and an ...
... will,hold a rally on Thursday, October 18, 2007, at 12 Noon ... When: October 18, 2007 Where: 175 E ... Noon CWA members have failed to ratify contracts containing proposals ... Services. CWA members are prepared to do whatever it,takes to secure ...
... Inc.,(Nasdaq: SUPG ), a pharmaceutical company dedicated ... for solid tumors and,hematological malignancies, today announced that ... the AACR-NCI-EORTC International,Conference from Oct. 22-26 at the ... presentations will focus on data concerning many of,SuperGen,s ...
... Oct. 17 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... devices in China, today announced that it will report,its ... closes on,November 1, 2007. Mindray,s management will hold an ... U.S. Eastern Time (8:00 AM on November,2, 2007 Beijing/Hong ...
... Corporation, a leading,developer of innovative clinical and ... today announced the immediate,availability of RxFYI, a ... RxFYI is free to participating pharmacies and ... revenue. "Patients want to learn more ...
Cached Medicine News:Health News:Food 'Pro' Cat Cora Teams Up With Sensodyne(R) ProNamel(TM) to Offer a Guide to Dining out with a Smile 2Health News:Food 'Pro' Cat Cora Teams Up With Sensodyne(R) ProNamel(TM) to Offer a Guide to Dining out with a Smile 3Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 2Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 3Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 4Health News:Ocular Pharma Company Charlesson Announces $2.35MM in New Funding 5Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 2Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 3Health News:Mindray to Report Third Quarter 2007 Financial Results on November 1, 2007 2Health News:Mirixa Debuts RxFYI - a Free Pharmacy-Published Health eNewsletter Building Patient Loyalty and Generating Revenue 2
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ... System as a non-invasive, wireless continuous glucose monitoring system, ... Chairman and Interim CEO of Echo Therapeutics, will present ... Conference. Mr. Doman will make a ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5